Table 1 Summary of the incident disease diagnoses within UK biobank cohort across two different follow up periods. Median follow-up time is based on the follow-up time from proteomic plasma measurement (baseline) until time to event (first diagnosis, death or censoring date, whichever occurs first).

From: Proteomic risk scores for predicting common diseases using linear and neural network models in the UK biobank

  

15 years follow-up

5 years follow up

Condition

Prevalent cases

(N)

Cases

(N)

Mean follow-up

time (SD)

Cases (N)

Mean

follow-up

time (SD)

Parkinson’s disease

42

430

8.67 (4.25)

102

2.81 (1.37)

Atrial fibrillation

619

3342

9.08 (4.24)

707

2.82 (1.43)

Asthma

2225

2849

7.43 (4.26)

951

2.64 (1.41)

COPD

381

2394

8.48 (4.22)

596

2.80 (1.39)

Dementia

10

1096

10.50 (3.59)

98

3.59 (1.23)

Depression

1034

2662

8.80 (4.05)

554

2.87 (1.45)

Type-2 Diabetes

646

2332

9.06 (4.11)

453

2.78 (1.44)

Endometriosis

298

184

6.28 (4.20)

85

2.57 (1.50)

Primary Malignancy – Pancreatic

4

185

9.68 (4.01)

34

3.35 (1.26)

Heart failure

247

2015

9.55 (4.29)

388

2.76 (1.45)

Motor neuron disease

29

288

7.19 (3.19)

81

3.31 (1.20)

Multiple sclerosis

226

167

7.25 (4.40)

61

2.58 (1.51)

Pulmonary embolism

163

895

9.33 (4.18)

162

2.89 (1.44)

Primary pulmonary hypertension

115

369

5.10 (3.13)

221

3.06 (1.39)

Primary Malignancy - Colorectal and anus

155

776

8.86 (4.38)

184

2.67 (1.40)

Primary Malignancy - Brain, Other CNS and Intracranial

12

125

8.25 (4.06)

36

3.33 (1.28)

Primary Malignancy – Breast

659

1217

8.04 (4.39)

359

2.71 (1.43)

Primary Malignancy - Lung and trachea

32

615

9.16 (4.10)

137

3.35 (1.28)

Primary Malignancy – Prostate

131

1268

9.04 (4.36)

287

2.73 (1.46)

Rheumatoid Arthritis

186

664

9.54 (3.66)

80

3.20 (1.47)

Schizophrenia

99

119

8.38 (4.30)

28

2.54 (1.72)

Lupus erythematosus

(local and systemic)

267

259

5.84 (3.48)

116

2.68 (1.36)

Psoriasis

474

476

7.89 (4.68)

156

2.38 (1.36)

Primary Malignancy – Gynaecological

126

332

7.98 (4.33)

107

2.88 (1.41)

Coronary heart disease

1296

4070

8.24 (4.39)

1137

2.63 (1.45)

Ischaemic stroke

93

921

9.79 (4.05)

148

2.98 (1.40)

End stage renal disease

39

177

9.39 (4.00)

28

2.88 (1.08)

  1. COPD: Chronic obstructive pulmonary disease